24 Jul 2012, BioSpectrum Bureau , BioSpectrum
Bangalore: Max Neeman International announced that they have provided data management services to over 60 countries and have completed 250 medical writing projects; key milestones for the company since it began operations in 2001.
Outsourcing of clinical research services, such as data management and medical writing, continues to grow as sponsors seek quality, reliable results that are more cost-effective. Mr Koteshwar Govind, head of Clinical Data Management states, "Reaching over 60 countries with our data management, biostatistical and CDISC solutions is very fulfilling and a testament to the company's customer-driven, customized approach. Independent of whether we run the trial or not, we can provide exemplary data management services that every clinical research trial needs. Solutions delivered are regulatory-compliant, secure and cost-effective."
Max Neeman uses SAS and SAS Clinical DI studio for mapping. There is complete implementation of SDTM compliance checks and ADaM (Analysis Data Model). The company has a dedicated and experienced core SAS Team for CDISC services, well trained by SAS global for effective and efficient execution of the projects. We also have well established processes for converting existing clinical study data [Legacy Data] in any format, into the standard CDISC SDTM and metadata format which can be submitted to the regulatory authority. The data warehousing facility adds value and renders maximum usability to the existing and legacy data.
In addition to providing data management services on Ph I-IV drug and medical device trials, Max Neeman International has been a trusted partner of numerous global pharmaceutical, biotech and device companies for medical writing services.